Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
DCGI nod for Jubilant’s generic remdesivir under brand name JUBI-R
The company will distribute the drug in the Indian market through its distribution network and will be available by the first week…
China’s indigenously developed COVID-19 vaccines set to surprise the world: GlobalData
China's Sinopharm and Sinovac (in collaboration with Brazil-based Butantan) have both reported encouraging results in the early…
Draw up immunisation strategy now itself for COVID-19 vaccine: Kiran Mazumdar-Shaw
"If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by…
Oxford University coronavirus vaccine induces immune response: Lancet
The findings are seen as promising, but experts feel it is too soon to know if this is enough to offer protection as larger trials…
Remdesivir treatment gains popularity in India, black marketing and price cuts to continue:…
According to figures compiled by the CDSCO, India will be producing 20,000 vials per day by the end of July.
Hand sanitisers under Schedule K: Pharma Inc happy, regulators cite concerns
Schedule-K will allow hand sanitisers to be sold without a sale license
Mylan commences supply of remdesivir in India under brand name DESREM
The company also launched a 24/7 helpline number to give out information about the availability of the drug
Cipla, Amgen settle case involving generic cinacalcet hydrochloride tablets
Cipla's cinacalcet hydrochloride tablets, in the strengths of 30mg, 60mg and 90mg, are generic versions of Sensipar, a branded…
DCGI queries pharma company on its claim of FabiFlu use for COVID-19 patients with comorbidities
As per statement by the Glenmark and media reports, the DCGI had accelerated the process for clinical trials and reviews…
Russia to mass produce experimental COVID-19 vaccine – wealth fund head
A larger Phase III trial involving several thousand people is expected to begin in August, said Russian Direct Investment Fund…